Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Imago BioSciences raises $26.5mm through Series A round; $14mm added

Executive Summary

Epigenetics start-up Imago BioSciences Inc. raised $26.5mm through its Series A round. Clarus Ventures led and was joined by Frazier Healthcare, Amgen Ventures, and Merck Research Labs Venture Fund. Clarus and Frazier representatives joined the company’s board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies